Cartesian Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of RNAC for the last quarter is 387.00 k USD, and it's 98.84% lower compared to the previous quarter. The net income of Q3 24 is -24.18 M USD.